Cancer research has come along way throughout the years. At one point in time, the industry was barely getting by thanks to its valiant efforts, but as of today, this exclusive community is thriving. The CEO of Seattle Genetics, Clay Siegall, has continued his mission of fighting this dangerous disease. His strong passion and perseverance has never wavered. He has saved thousands of lives over the years thanks to his brilliant way of thinking, and his company is the weapon of choice. Located in Bothell, Washington, Seattle Genetics has grown into the top cancer research organization in the world, and it produces the best cancer fighting medications. These are known as anti-body drug conjugates. The medications have helped Seattle Genetics bring in over $350 million. In just over the past half decade, the company has tripled its stock and this didn’t happen by chance.
Dr. Siegall’s role at Seattle Genetics can’t be denied because he’s the heart and the soul of the business. The guy is known as a man of many acts thanks to his many professional titles. This includes being an entrepreneur, a scientist, a doctor and an author. He has written 70 successful publications, and he currently holds at least 15 patents. That is more than most doctors even if you combined them. His focus in the advancement in fighting cancer is what sets him apart. Dr. Siegall has been in this business for more than 20 years, and he has worked alongside of major brand names like the National Cancer Society, the National Institute of Cancer, Bristol Myers Squibb and others.
His extensive education also adds to his legendary status as he has a B.S. in Zoology from the University of Maryland and a Ph.D in Genetics from George Washington University. Dr. Clay Siegall is definitely setting new standards and Seattle Genetics has raised the bar even higher than before.